Overview

Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

Status:
Completed
Trial end date:
2017-09-25
Target enrollment:
Participant gender:
Summary
This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia rescue of adult patients with type 1 diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Xeris Pharmaceuticals
Treatments:
Glucagon
Glucagon-Like Peptide 1